GlaxoSmithKline PLC ADR (GSK) — Capital Reinvestment Ratio
GlaxoSmithKline PLC ADR (GSK) has a Capital Reinvestment Ratio of 0.39x as of March 2026, meaning it reinvests 0% of its operating cash flow ($1.14 Billion) in capital expenditures ($443.00 Million). See net asset quality index of GlaxoSmithKline PLC ADR to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
GlaxoSmithKline PLC ADR Capital Reinvestment Ratio (1990–2025)
This chart tracks GlaxoSmithKline PLC ADR's Capital Reinvestment Ratio across 36 annual periods. Check GlaxoSmithKline PLC ADR total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for GlaxoSmithKline PLC ADR (1990–2025)
Year-by-year Capital Reinvestment Ratio for GlaxoSmithKline PLC ADR from 1990 to 2025. For live market cap and broader valuation context, see GSK company net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.18x | $7.14 Billion | $1.32 Billion | ▼ -59.4% |
| 2024 | 0.45x | $6.55 Billion | $2.98 Billion | ▲ +119.8% |
| 2023 | 0.21x | $7.89 Billion | $1.63 Billion | ▼ -32.1% |
| 2022 | 0.31x | $7.40 Billion | $2.26 Billion | ▼ -17.2% |
| 2021 | 0.37x | $7.95 Billion | $2.93 Billion | ▲ +39.0% |
| 2020 | 0.27x | $8.44 Billion | $2.24 Billion | ▼ -1.6% |
| 2019 | 0.27x | $8.02 Billion | $2.16 Billion | ▲ +26.5% |
| 2018 | 0.21x | $8.42 Billion | $1.80 Billion | ▼ -33.0% |
| 2017 | 0.32x | $6.92 Billion | $2.20 Billion | ▼ -12.1% |
| 2016 | 0.36x | $6.50 Billion | $2.35 Billion | ▼ -51.1% |
| 2015 | 0.74x | $2.57 Billion | $1.90 Billion | ▲ +118.7% |
| 2014 | 0.34x | $5.18 Billion | $1.75 Billion | ▲ +43.6% |
| 2013 | 0.24x | $7.22 Billion | $1.70 Billion | ▼ -32.2% |
| 2012 | 0.35x | $4.38 Billion | $1.52 Billion | ▲ +63.5% |
| 2011 | 0.21x | $6.25 Billion | $1.33 Billion | ▼ -11.7% |
| 2010 | 0.24x | $6.80 Billion | $1.64 Billion | ▲ +0.7% |
| 2009 | 0.24x | $7.84 Billion | $1.87 Billion | ▼ -15.6% |
| 2008 | 0.28x | $7.31 Billion | $2.07 Billion | ▼ -23.5% |
| 2007 | 0.37x | $5.79 Billion | $2.14 Billion | ▼ -7.9% |
| 2006 | 0.40x | $3.96 Billion | $1.59 Billion | ▲ +90.0% |
| 2005 | 0.21x | $5.59 Billion | $1.18 Billion | ▲ +295.2% |
| 2004 | 0.05x | $4.77 Billion | $255.00 Million | ▼ -75.6% |
| 2003 | 0.22x | $4.85 Billion | $1.06 Billion | ▼ -45.4% |
| 2002 | 0.40x | $3.06 Billion | $1.23 Billion | ▲ +65.4% |
| 2001 | 0.24x | $4.61 Billion | $1.12 Billion | ▼ -59.3% |
| 2000 | 0.60x | $1.85 Billion | $1.10 Billion | ▼ -49.1% |
| 1999 | 1.17x | $510.00 Million | $597.00 Million | ▲ +1.0% |
| 1998 | 1.16x | $410.00 Million | $475.00 Million | ▲ +71.7% |
| 1997 | 0.67x | $615.00 Million | $415.00 Million | ▲ +42.9% |
| 1996 | 0.47x | $849.00 Million | $401.00 Million | ▼ -13.5% |
| 1995 | 0.55x | $1.25 Billion | $684.00 Million | ▲ +175.5% |
| 1994 | 0.20x | $2.45 Billion | $485.59 Million | ▼ -63.7% |
| 1993 | 0.55x | $1.05 Billion | $575.00 Million | ▼ -16.7% |
| 1992 | 0.66x | $927.00 Million | $608.00 Million | ▼ -27.5% |
| 1991 | 0.90x | $657.00 Million | $594.00 Million | ▼ -8.2% |
| 1990 | 0.99x | $615.00 Million | $606.00 Million | — |